FINWIRES · TerminalLIVE
FINWIRES

Update: WTI Falls Again on Hopes a Deal to End the Iran War is Near

By

-- West Texas Intermediate (WTI) crude oil fell for a third-straight session on Thursday but rose off the day's low on uncertain prospects for a potential peace deal between the United States and Iran.

WTI crude oil for June delivery closed down US$0.27 to settle at US$94.81 per barrel, after earlier touching US$89.85. July Brent oil was last seen down US$0.67 to US$100.60

The drop, which follows on Wednesday's 7% fall for WTI prices, comes amid rising optimism the United States and Iran are closer to a peace deal. However the outlook for a deal is uncertain. The Guardian reported while U.S. President Trump is saying a deal is "very possible", Iranian media are reporting is only reviewing the proposal and considering its response.

There is no certainty talks will result in a deal between the two countries that will see a quick reopening of the Strait of Hormuz, the chokepoint for exports from Persian Gulf nations that supplied 20% of the world's daily oil demand. More than 1,000 ships have been trapped in the Gulf since the Feb. 28 start to the war and supplies of oil, refined products, LNG, fertilizer and other commodities are running short.

"We should not be too optimistic about immediate agreement. A spokesperson for the Iranian finance ministry pushed back yesterday, calling parts of the US framework "ambitious and unrealistic proposals". So far, Tehran's wish list: set out in its 14-point response on May 2, is unchanged: full sanctions relief, release of frozen state assets, ~$270bn in reparations / reconstruction financing ("only way" to end the conflict), and a new multilateral mechanism for the SoH (Strait of Hormuz) that effectively recognizes Iranian sovereignty over it," Ole Hvalbye, a commodities analyst at SEB Research, wrote.

Related Articles

Sectors

Sector Update: Consumer Stocks Edge Lower Late Afternoon

Consumer stocks were edging down late Thursday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) each decreasing 0.1%.In corporate news, Tapestry (TPR) raised its fiscal 2026 outlook after delivering a Q3 beat, but provided a subdued Q4 sales guidance for its Kate Spade brand. Its shares dropped more than 13%.Shake Shack (SHAK) shares slumped 28% after the company's Q1 results missed Wall Street estimates.Planet Fitness (PLNT) shares tumbled 32% after the company tempered its full-year outlook amid fewer-than-expected member additions in Q1.McDonald's (MCD) reported better-than-expected Q1 results as comparable sales rebounded more than market estimates despite what the company described as a "challenging" environment. Its shares rose 0.3%.

$MCD$PLNT$SHAK$TPR
Sectors

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index decreasing 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.7%.The iShares Biotechnology ETF (IBB) dropped 2.2%.In corporate news, Entrada Therapeutics (TRDA) shares tumbled 57% after its drug for children with Duchenne muscular dystrophy fell short of analyst expectations in an early-to-mid stage trial, Reuters reported Thursday.Iovance Biotherapeutics (IOVA) shares fell past 13% after the company's Q1 loss narrowed less than expected and revenue missed estimates.Harmony Biosciences (HRMY) shares dropped 5.5% after the company's Q1 earnings and revenue fell short of analysts' estimates.Catalyst Pharmaceuticals (CPRX) shares rose 2.1% after the company agreed to be acquired by Angelini Pharma in a deal with an equity value of about $4.1 billion. The company also said it has reached a settlement agreement with Hetero Labs to resolve patent litigation regarding a proposed generic version of Firdapse.

$CPRX$HRMY$IOVA$TRDA
Research

Cascades Target Eased To C$13 From $14, Keeps Sector Perform at National Bk Which Notes Q1 In Line With Reduced Outlook, Soft Q2 Outlook Before Recovery, Asset Sales Done By Q3

Price: $10.72, Change: $-0.23, Percent Change: -2.10%

$CAS.TO